Avascular Necrosis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2028

  • Single User License $3500

Avascular Necrosis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2028

Status : May, 2021 | Pharmaceutical

Report Digest

Avascular Necrosis Market: Overview

Avascular necrosis (AVN) also named as aseptic necrosis, osteonecrosis, or ischemic bone necrosis, is a condition bringing about the death of bone cells because of lack of blood supply. It frequently leads fall of the joint surface and consequent joint inflammation because of an irregular joint surface. Avascular necrosis influences the closures (epiphysis) of long bones, for example, upper humerus, femur, and bones of lower leg joint. Normally it occurs because of combination of different factors including genetic, metabolic, increased consumption of alcohol, smoking, and different ailments.

Usually, in order to treat avascular necrosis, the nonsurgical treatment methods are used, for example, changes in daily activities, anti-inflammatory medications, and crutches are the major source of treatment to help in reducing the progress of the disease and in pain relief. Surgical treatment comprise cartilage and bone grafting, core decompression, and entire hip replacement. On the basis of the cause, avascular necrosis is categorized into non-traumatic and traumatic avascular necrosis.

Avascular Necrosis Market: Trends and Opportunities

Increased consumption of alcohol for a long time, heavy dose of systematic corticosteroid utilize are the significant hazard factors for avascular necrosis.

Other serious factors or conditions related with non-traumatic osteonecrosis incorporate cancer, autoimmune illness, Gaucher disorder, decompression illness (Caisson ailment), HIV infection, pancreatitis, and blood issue, for example, sickle cell infection. Certain treatment including chemotherapy and radiation treatment can cause osteonecrosis as well. Besides, individuals who have experienced organ transplants are at high risk of osteonecrosis.

Advanced technologies related to treatments for avascular necrosis, for example, Advanced Therapy Medicinal Products (ATMPs) is likely to help avascular necrosis market. Advanced Therapy Medicinal Products is a class of advanced treatments that includes quality treatment, physical cell treatment, and tissue-engineered products.

Increased expense of surgical treatments and delayed diagnosis because of asymptomatic nature of this condition at beginning are the major hindering factors for avascular necrosis market development.

Avascular Necrosis Market: Market Potential

Creators evaluated the long term clinical result and implant survivorship of patients that experienced unicompartmental knee arthroplasty (UKA) for knee avascular necrosis. They reflectively investigated 29 back to back UKA carried out by two senior specialists in 28 patients with unicompartmental avascular necrosis of the knee (AVN) somewhere during 1989 and 2001. In the longest span till date, discoveries proposed a association of UKA for treatment of AVN with increased survival rates and stable clinical enhancement. With the end goal to treat patients with unicompartmental osteonecrosis of the knee, UKA is a productive alternative.

Avascular Necrosis Market: Regional Outlook

North America is foreseen to develop a noteworthy revenue in global avascular necrosis market in the forthcoming years because of rising prevalence of avascular necrosis and earlier Food and Drug Administration (FDA) consent for the new avascular necrosis medications in the region.

Moreover, Asia Pacific avascular necrosis market is as well foreseen to anticipate most elevated development during coming years, inferable from rise in development activities for the treatment of avascular necrosis by various key players in the region.

Avascular Necrosis Market: Competitive Landscape

Major players operating in the global avascular necrosis market are Boehringer Ingelheim GmbH, Bone Therapeutics, Bayer AG, Ethicon Inc., Enzo Biochem Inc., Eli Lilly and Company, Integra LifeSciences Corporation, Grifols SA, K-Stemcell Co Ltd., Merck KGaA, Medtronic Plc, Pfizer Inc., Stryker Corporation, Sanofi SA, Zimmer Biomet Holdings, and Wright Medical Group N.V.

This study provides a particularized anatomy according to the L.E.A.P mechanism

  • Latest trends and cardinal growth prospects
  • Existing and future insights in growth
  • Ascensions in technology
  • Pain points

The regional analysis offers market assays across:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study, prepared through the L.E.A.P mechanism adds a dimension of infallibility and assures precise information on all the growth dynamics.

Latest Trends and Cardinal Growth Prospects

The study assists in burnishing the knowledge of the stakeholder in terms of the emerging trends. The study provides an expansive coverage on the latest developments and novel profit-yielding sources that augur well with the market. A dedicated and determined team of experts conduct an out-and-out research on diverse aspects to offer ultimate breakthroughs in the market.

Existing and Future Insights in Growth

The interfusion of ubiquitous primary and secondary research through modern tools invites perfection and accuracy in every aspect. Primary research is circumspectly conducted through exhaustive interactions and interviews of experts. These valuable opinions are then neatly inducted in the report to allow the stakeholder for reaping the benefits. A treasure of secondary data is extracted via famed paid sources, yearly estimates and statements, renowned journals, and government documents. These sources assist in creating a robust database comprising existing and subsequent growth dynamics.

Ascensions in Technology

Diverse technological advancements and cutting-edge innovations in the market have been covered in this study to assist the stakeholder in research and development activities. Recent upgrades have also been added in the study, thus helping the stakeholder to paint the strokes of growth on the canvas of the market.

Pain Points

The study presents a plethora of challenges and obstacles that can hinder the growth of the market to allow the stakeholder to prepare their strategies accordingly.

The world ushered in the new decade with the shadow of the COVID-19 pandemic. The outbreak has damaged the growth prospects of several businesses and has crippled the entire economy. The study is in tandem with the changing dynamics of the market due to the SARS-CoV-2 outbreak. The study focuses on the coronavirus pandemic and analyses every aspect that impacts the growth positively or negatively.

An aerial perspective of the regions covered in this study enables the stakeholder to design strategies accordingly. The 360-degree assessment of every aspect associated with growth offers information on a rainbow of growth opportunities available across the market.

The exhaustive study motivates the stakeholder to take the 'LEAP' of faith and achieve success!

This report is the key to questions such as:

What are the prominent factors that will help in reshaping the market growth?

Which trends have the potential to bring expansive growth for the market?

What are the necessary strategies to overcome the ill-effects of the COVID-19 pandemic?

Which regions will emerge as champion growth contributors for the market?

Which aspects will serve as game-changers for the market?

What are the latest innovations in the market?

Which factors will hinder the growth of the market?